FTO‐mediated m6A demethylation regulates IGFBP3 expression and AKT activation through IMP3‐dependent P‐body re‐localisation in lung cancer
Abstract Lung cancer remains one of the leading causes of cancer‐related deaths worldwide, and a growing body of evidence suggests that RNA modifications, including methylation, play a critical role in its progression. In this study, we investigated the role of the RNA demethylase fat mass and obesi...
Saved in:
| Main Authors: | Haiyang Wang, Hui Peng, Zhenzhen Zhang, Yilimunuer Abulimiti, Jiayi Hu, Yongxin Zhou, Ping Ji, Dong Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-07-01
|
| Series: | Clinical and Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ctm2.70392 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IGFBP2 and IGFBP4 interact to activate complement pathway in diabetic kidney disease
by: Jieling Liang, et al.
Published: (2025-12-01) -
FTO Facilitates Cervical Cancer Malignancy Through Inducing m6A‐Demethylation of PIK3R3 mRNA
by: Bingxin Chen, et al.
Published: (2024-12-01) -
IGFBP3-mediated effects of an effective combination therapy on HCC
by: Lin Chen, et al.
Published: (2025-08-01) -
IGFBP2 Modulates Trophoblast Function and Epithelial–Mesenchymal Transition in Preeclampsia via the PI3K/AKT Signaling Pathway
by: Shengping Meng, et al.
Published: (2025-06-01) -
Integrated multi-omics profiling to establish an IGFBP-based prognostic score for pancreatic ductal adenocarcinoma: unraveling prognostic biomarkers, immune microenvironment crosstalk, and therapeutic implications
by: Xiao Guan, et al.
Published: (2025-05-01)